Sumera H. Qureshi
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort.
Journal: EULAR rheumatology open
Published: September 01, 2026
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Rheumatology
Published: November 11, 2025
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Journal: Lancet (London, England)
Published: August 21, 2023
Relapsing polychondritis - A single Centre study in the United Kingdom.
Journal: Autoimmunity reviews
Published: April 06, 2023
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY.
Journal: The Lancet. Rheumatology
Published: November 30, 2022
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 12, 2020
Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.
Journal: Thrombosis and haemostasis
Published: December 17, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026